ACEP’s “Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in…
Strokes that happen in the hospital aren’t evaluated and treated as quickly as strokes that happen in…
For the last decade and a half, patients presenting with acute ischemic stroke have had one active…
In 2013, ACEP updated its clinical policy for the use of intravenous tissue plasminogen activator (tPA) for…
The Case “Hey, Doc, we got a possible stroke going into room 9.” The EMS team arrived.”…
In response to amended Resolution 32 from the 2013 Council meeting, the ACEP Board of Directors instructed…
Revising the use of thrombolytics in ischemic stroke could reverse nationally accepted practices, guidelines in the ED…
Comments related to guidelines about use of intravenous thrombolytics for ischemic stroke must be submitted to ACEP…
The Clinical Policies Committee will review ACEP members’ comments and supporting evidence through March 24 In response…
Representative Raul Ruiz, MD, MPH, a former ED physician, steps up to aid a sick airline passenger…